Invacare Corporation
IVC · NYSE
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.00 | 0.05 |
| FCF Yield | -129.87% | -57.72% | -69.62% | 0.27% |
| EV / EBITDA | -23.53 | -15.73 | -16.27 | -36.67 |
| Quality | ||||
| ROIC | -5.23% | -2.15% | -4.93% | -2.60% |
| Gross Margin | 26.49% | 26.64% | 18.41% | 25.39% |
| Cash Conversion Ratio | 0.74 | 0.41 | 0.58 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.18% | -4.47% | -2.91% | -1.65% |
| Free Cash Flow Growth | -268.15% | 56.75% | -16,742.28% | 100.41% |
| Safety | ||||
| Net Debt / EBITDA | -21.01 | -15.17 | -15.04 | -32.34 |
| Interest Coverage | -3.42 | -1.38 | -3.55 | -2.37 |
| Efficiency | ||||
| Inventory Turnover | 1.17 | 1.18 | 1.15 | 1.02 |
| Cash Conversion Cycle | 67.93 | 49.05 | 58.31 | 60.69 |